CYH Community Health Systems, Inc. Common Stock
Community Health Systems, Inc. Common Stock 정보 위키백과 회사 개요
Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
더 보기
Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.
On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.
Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.
History
Founding and early years (1985–2014)
E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.
The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.
In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.
In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.
In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.
In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.
In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.
On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.
It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.
Recent developments (2015–present)
On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.
In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.
After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.
On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.
In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.
In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.
In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.
On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.
On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.
On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.
In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.
On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.
On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.
In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.
In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.
Predatory liens practices
Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
CYH 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
CYH 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
배당금 배당 수익률, 지급 비율, 배당 이력, 5년 CAGR
| 배당락일 | 금액 |
|---|---|
| 2012년 12월 13일 | $0.2066 |
CYH 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 1 6.2%
- 매수 1 6.2%
- 보유 6 37.5%
- 매도 7 43.8%
- 적극 매도 1 6.2%
12개월 목표 주가
7 명의 애널리스트 · 2026-08-13실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.19 | $-0.06 | -0.13% |
| 2026년 3월 31일 | $-0.48 | $-0.10 | -0.38% |
| 2025년 12월 31일 | $-0.01 | $-0.10 | 0.10% |
| 2025년 9월 30일 | $1.27 | $-0.25 | 1.5% |
| 2025년 6월 30일 | $-0.05 | $-0.11 | 0.06% |
| 2025년 3월 31일 | $-0.03 | $-0.08 | 0.05% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| CYH | $433M | 0.8 | -1.2% | 4.1% | -30.8% | — |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | — |
| ARDT | $1.26B | 9.2 | 6.0% | 2.1% | 11.2% | — |
| NUTX | $1.17B | 15.7 | 82.4% | 8.1% | 30.6% | 50.8% |
| USPH | — | 55.0 | 16.3% | 5.1% | 8.2% | 19.2% |
| JYNT | $123M | 45.9 | 5.2% | 5.3% | 16.3% | — |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Cost of Revenue | $1.86B | $1.95B | $1.99B | $1.98B | $2.04B | $1.96B | $2.15B | $2.35B | $2.67B | $3.01B | |
| Operating Expenses | $11.00B | $12.09B | $11.53B | $11.39B | $10.97B | $10.66B | $12.56B | $13.95B | $17.23B | $19.30B | |
| Operating Income | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $650M | $208M | $-1.88B | $-860M | |
| Interest Income | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $7M | $11M | $14M | |
| Pretax Income | $724M | $-283M | $207M | $349M | $499M | $422M | $-430M | $-715M | $-2.83B | $-1.72B | |
| Income Tax | $48M | $79M | $191M | $170M | $131M | $-185M | $160M | $-11M | $-449M | $-104M | |
| Net Income | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| EPS (Basic) | $3.81 | $-3.90 | $-1.02 | $0.35 | $1.82 | $4.43 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| EPS (Diluted) | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 | $4.39 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| Shares (Basic) | 133,564,227 | 132,101,768 | 130,445,677 | 128,808,387 | 126,754,852 | 115,491,022 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| Shares (Diluted) | 135,012,240 | 132,101,768 | 130,445,677 | 130,060,319 | 130,597,410 | 116,544,561 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| EBITDA | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $1.26B | $908M | $-1.02B | $240M |
대차대조표 26
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $260M | $37M | $38M | $118M | $507M | $1.68B | $216M | $196M | $563M | $238M | |
| Receivables | $2.08B | $2.29B | $2.23B | $2.04B | $2.06B | $1.93B | $2.26B | $2.35B | $2.38B | $3.18B | |
| Other Current Assets | $381M | $358M | $275M | $235M | $269M | $338M | $358M | $400M | $462M | $568M | |
| Current Assets | $3.23B | $3.30B | $3.21B | $3.08B | $3.48B | $4.51B | $3.43B | $3.55B | $4.07B | $4.67B | |
| PP&E (Net) | $4.50B | $4.78B | $5.21B | $5.37B | $5.55B | $5.32B | $5.61B | $6.14B | $7.05B | $8.15B | |
| PP&E (Gross) | $8.91B | $9.16B | $9.51B | $9.64B | $9.76B | $9.35B | $9.65B | $10.30B | $11.50B | $12.42B | |
| Accum. Depreciation | $4.41B | $4.38B | $4.30B | $4.27B | $4.20B | $4.03B | $4.04B | $4.16B | $4.45B | $4.27B | |
| Goodwill | $3.32B | $3.79B | $3.96B | $4.17B | $4.22B | $4.22B | $4.33B | $4.56B | $4.72B | $6.52B | |
| Intangibles | $7M | $15M | $20M | $2M | · | · | · | · | $10M | $14M | |
| Other Non-current Assets | $2.10B | $2.17B | $2.05B | $2.01B | $1.91B | $1.90B | $2.21B | $1.54B | $1.54B | $2.59B | |
| Total Assets | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Accounts Payable | $842M | $913M | $912M | $773M | $830M | $783M | $811M | $887M | $967M | $995M | |
| Accrued Liabilities | · | · | · | · | · | · | $1.13B | $1.09B | $1.13B | $1.23B | |
| Current Liabilities | $2.21B | $2.35B | $2.14B | $2.19B | $2.36B | $2.81B | $2.28B | $2.39B | $2.36B | $2.89B | |
| Capital Leases | $537M | $535M | $563M | $605M | $535M | $524M | $487M | $84M | $287M | $302M | |
| Deferred Tax | $25M | $231M | $369M | $354M | $192M | $29M | $200M | $26M | $19M | $411M | |
| Other Non-current Liabilities | $891M | $828M | $739M | $644M | $827M | $1.60B | $894M | $1.01B | $1.36B | $1.57B | |
| Total Liabilities | $14.04B | $15.37B | $15.28B | $15.40B | $16.03B | $17.06B | $17.25B | $16.82B | $17.61B | $19.66B | |
| Long-term Debt | $10.40B | $11.45B | $11.49B | $11.63B | $12.14B | $12.22B | $13.40B | $13.60B | $13.91B | $15.24B | |
| Total Debt | $10.38B | $11.43B | $11.47B | $11.61B | $12.11B | $12.09B | $13.38B | · | · | · | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Retained Earnings | $-3.57B | $-4.08B | $-3.56B | $-3.43B | $-3.48B | $-3.71B | $-4.22B | $-3.54B | $-2.76B | $-299M | |
| AOCI | $-9M | $-10M | $-14M | $-21M | $-14M | $-13M | $-9M | $-10M | $-21M | $-62M | |
| Stockholders' Equity | $-1.39B | $-1.91B | $-1.39B | $-1.37B | $-1.37B | $-1.62B | $-2.22B | $-1.53B | $-767M | $1.61B | |
| Liabilities + Equity | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Shares Outstanding | 138,626,917 | 138,919,641 | 136,774,911 | 134,703,717 | 132,146,282 | 129,612,117 | 117,822,631 | 116,248,376 | 114,651,004 | 113,876,580 |
현금 흐름 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $426M | $486M | $505M | $534M | $540M | $558M | $608M | $700M | $861M | $1.10B | |
| Stock-based Comp | $11M | $17M | $22M | $20M | $25M | $13M | $10M | $13M | $24M | $46M | |
| Deferred Tax | $-243M | $-116M | $35M | $165M | $171M | $-187M | $203M | $-3M | $-454M | $-116M | |
| Restructuring | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | $239M | $352M | $2.80B | $1.83B | |
| Operating Cash Flow | $543M | $480M | $210M | $300M | $-131M | $2.18B | $385M | $274M | $773M | $1.14B | |
| CapEx | $335M | $360M | $467M | $415M | $469M | $440M | $438M | $527M | $564M | $744M | |
| Investing Cash Flow | $847M | $-275M | $-26M | $-259M | $-524M | $177M | $-2M | $-245M | $1.07B | $630M | |
| Net Debt Issued | $-6.52B | $-5.06B | $-4.32B | $-2.36B | $-4.43B | $-5.49B | $-3.56B | $-2.03B | $-5.39B | $-6.71B | |
| Financing Cash Flow | $-1.17B | $-206M | $-264M | $-430M | $-514M | $-895M | $-363M | $-396M | $-1.52B | $-1.71B | |
| Net Change in Cash | $223M | $-1M | $-80M | $-389M | $-1.17B | $1.46B | $20M | $-367M | $325M | $54M | |
| Taxes Paid | $249M | $171M | $91M | $-6M | $-4M | $-2M | $3M | $19M | $-4M | $16M | |
| Free Cash Flow | $208M | $120M | $-257M | $-115M | $-600M | $1.74B | $-53M | $-253M | $209M | $393M |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 4.9% | 1.5% | · | · | |
| Net Margin | 4.1% | -4.1% | -1.1% | 0.38% | 1.9% | 4.3% | -5.1% | -5.6% | · | · | |
| Pretax Margin | 5.8% | -2.2% | 1.7% | 2.9% | 4.0% | 3.6% | -3.3% | -5.1% | · | · | |
| EBITDA Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 9.5% | 6.4% | · | · | |
| ROA | 3.7% | -3.6% | -0.91% | 0.31% | 1.5% | 3.2% | -4.3% | -4.7% | -12.5% | -7.1% | |
| ROE | -30.8% | 31.2% | 9.6% | -3.4% | -15.3% | -26.6% | 36.0% | 68.5% | -580.0% | -61.1% | |
| ROIC | 15.5% | 7.3% | 0.73% | 4.1% | 9.6% | 15.5% | 8.0% | -13.3% | 206.0% | -50.0% |
유동성 및 지급능력 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 | 1.6 | 1.5 | 1.5 | 1.7 | 1.6 | |
| Quick Ratio | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 | 1.1 | 1.1 | 1.3 | 1.2 | |
| Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · | |
| LT Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | |
| Receivables Turnover | 5.7 | 5.6 | 5.8 | 6.0 | 6.2 | 5.6 | 5.7 | 6.0 | · | · |
성장률 9
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.2% | 1.1% | 2.3% | -1.3% | 4.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.74% | 0.71% | 1.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.1% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -80.1% | -59.9% | · | · | · | · | · | |
| EPS CAGR 3Y | 120.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -80.0% | -55.0% | · | · | · | · | · | |
| Net Income CAGR 3Y | 122.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.08% | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Net Income TTM | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| Market Cap | $433M | $415M | $428M | $582M | $1.76B | $963M | $342M | $328M | $488M | $637M | |
| Enterprise Value | $10.55B | $11.81B | $11.86B | $12.08B | $13.36B | $11.38B | $13.51B | · | · | · | |
| P/E | 0.8 | -0.8 | -3.1 | 12.3 | 7.6 | 1.7 | -0.5 | -0.4 | -0.2 | -0.4 | |
| P/S | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| P/B | -0.3 | -0.2 | -0.3 | -0.4 | -1.3 | -0.6 | -0.2 | -0.2 | -0.6 | 0.4 | |
| P / Cash Flow | 0.8 | 0.9 | 2.0 | 1.9 | -13.4 | 0.4 | 0.9 | 1.2 | 0.6 | 0.6 | |
| P / FCF | 2.1 | 3.5 | -1.7 | -5.1 | -2.9 | 0.6 | -6.4 | -1.3 | 2.3 | 1.6 | |
| EV / EBITDA | 7.1 | 21.8 | 12.4 | 14.7 | 9.5 | 10.1 | 10.7 | · | · | · | |
| EV / FCF | 50.7 | 98.4 | -46.1 | -105.0 | -22.3 | 6.5 | -254.9 | · | · | · | |
| EV / Revenue | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 1.0 | 1.0 | · | · | · | |
| Earnings Yield | 120.8% | -130.4% | -32.6% | 8.1% | 13.2% | 59.1% | -204.5% | -247.9% | -516.4% | -278.0% |
손익계산서 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.83B | $2.96B | $3.11B | $3.09B | $3.13B | $3.16B | $3.26B | $3.09B | $3.14B | $3.14B | $3.18B | $3.09B | $3.12B | $3.11B | $3.14B | $3.02B | |
| Cost of Revenue | $401M | $441M | $446M | $460M | $469M | $489M | $507M | $469M | $483M | $487M | $493M | $489M | $504M | $507M | $497M | $492M | |
| Operating Expenses | $2.44B | $2.68B | $2.66B | $2.84B | $2.62B | $2.88B | $2.99B | $3.29B | $2.90B | $2.91B | $2.85B | $2.91B | $2.87B | $2.90B | $2.91B | $2.82B | |
| Operating Income | $389M | $281M | $449M | $243M | $512M | $284M | $278M | $-205M | $238M | $231M | $328M | $173M | $246M | $210M | $228M | $204M | |
| Interest Income | $1M | $1M | $0 | $1M | $1M | · | $1M | $1M | · | · | · | · | · | · | · | · | |
| Pretax Income | $180M | $64M | $221M | $-2M | $438M | $67M | $64M | $-419M | $50M | $22M | $194M | $-33M | $40M | $6M | $324M | $70M | |
| Income Tax | $76M | $89M | $61M | $-173M | $118M | $42M | $91M | $-64M | $24M | $28M | $108M | $19M | $38M | $26M | $-123M | $70M | |
| Net Income | $70M | $-58M | $110M | $130M | $282M | $-13M | $-71M | $-391M | $-13M | $-41M | $47M | $-91M | $-38M | $-51M | $415M | $-42M | |
| EPS (Basic) | $0.51 | $-0.43 | $0.83 | $0.97 | $2.11 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| EPS (Diluted) | $0.51 | $-0.43 | $0.82 | $0.96 | $2.09 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| Shares (Basic) | 135,494,789 | 134,417,158 | -266,863,732 | 133,787,535 | 133,763,733 | 132,876,691 | -263,891,006 | 132,376,226 | 132,344,504 | 131,272,044 | -260,601,819 | 130,698,907 | 130,659,672 | 129,688,917 | -257,247,066 | 129,141,673 | |
| Shares (Diluted) | 136,505,102 | 134,417,158 | -267,935,024 | 135,187,592 | 134,882,981 | 132,876,691 | -263,891,006 | 132,376,226 | 132,344,504 | 131,272,044 | -260,601,819 | 130,698,907 | 130,659,672 | 129,688,917 | -255,995,134 | 129,141,673 | |
| EBITDA | $389M | $281M | · | $243M | $512M | $284M | · | $-205M | $238M | $231M | · | $173M | $246M | $210M | · | $204M |
대차대조표 25
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $149M | $712M | $260M | $123M | $456M | $431M | $37M | $33M | $39M | $48M | · | $91M | $118M | $144M | · | $300M | |
| Receivables | $2.14B | $2.14B | $2.08B | $2.16B | $2.26B | $2.33B | $2.29B | $2.04B | $2.19B | $2.19B | · | $2.16B | $2.04B | $2.04B | · | $1.97B | |
| Other Current Assets | $308M | $421M | $381M | $325M | $351M | $61M | $358M | $402M | $292M | $307M | · | $325M | $339M | $227M | · | $301M | |
| Current Assets | $3.08B | $3.77B | $3.23B | $3.20B | $3.66B | $3.41B | $3.30B | $3.11B | $3.20B | $3.17B | · | $3.25B | $3.19B | $3.11B | · | $3.27B | |
| PP&E (Net) | $4.18B | $4.20B | $4.50B | $4.62B | $4.66B | $4.74B | $4.78B | $4.96B | $5.22B | $5.22B | · | $5.16B | $5.25B | $5.25B | · | $5.45B | |
| PP&E (Gross) | $8.04B | $8.09B | $8.91B | $9.06B | $9.02B | $9.20B | $9.16B | $9.09B | $9.59B | $9.61B | · | $9.37B | $9.53B | $9.56B | · | $9.73B | |
| Accum. Depreciation | $3.86B | $3.89B | $4.41B | $4.44B | $4.37B | $4.46B | $4.38B | $4.13B | $4.37B | $4.39B | · | $4.21B | $4.28B | $4.30B | · | $4.28B | |
| Goodwill | $3.23B | $3.13B | $3.32B | $3.54B | $3.60B | $3.79B | $3.79B | $3.94B | $3.97B | $3.96B | $3.96B | $3.94B | $4.05B | $4.05B | $4.17B | $4.20B | |
| Intangibles | · | · | $7M | · | · | · | $15M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.65B | $2.05B | $2.10B | $1.81B | $1.71B | $1.94B | $2.17B | $1.86B | $1.99B | $2.04B | · | $2.27B | $2.10B | $2.15B | · | $1.94B | |
| Total Assets | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Accounts Payable | $713M | $790M | $842M | $894M | $970M | $974M | $913M | $842M | $896M | $941M | · | $837M | $736M | $712M | · | $820M | |
| Current Liabilities | $2.02B | $2.57B | $2.21B | $2.18B | $2.29B | $2.37B | $2.35B | $2.13B | $2.17B | $2.14B | · | $2.15B | $2.08B | $2.13B | · | $2.38B | |
| Capital Leases | $527M | $504M | $537M | $527M | $514M | $535M | $535M | $528M | $542M | $546M | · | $560M | $580M | $588M | · | $563M | |
| Deferred Tax | $25M | $25M | $25M | $30M | $240M | $205M | $231M | $239M | $351M | $354M | · | $344M | $362M | $351M | · | $477M | |
| Other Non-current Liabilities | $901M | $922M | $891M | $866M | $850M | $806M | $828M | $815M | $721M | $726M | · | $694M | $722M | $647M | · | $726M | |
| Total Liabilities | $13.02B | $14.14B | $14.04B | $14.19B | $14.74B | $15.22B | $15.37B | $15.18B | $15.29B | $15.29B | · | $15.57B | $15.47B | $15.41B | · | $16.09B | |
| Long-term Debt | · | · | $10.40B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $9.55B | $10.13B | · | $10.59B | $10.84B | $11.30B | · | $11.47B | $11.50B | $11.53B | · | $11.82B | $11.73B | $11.70B | · | $11.94B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Retained Earnings | $-3.56B | $-3.63B | $-3.57B | $-3.68B | $-3.81B | $-4.09B | $-4.08B | $-4.01B | $-3.62B | $-3.60B | · | $-3.61B | $-3.52B | $-3.48B | · | $-3.85B | |
| AOCI | $-11M | $-10M | $-9M | $-5M | $-5M | $-7M | $-10M | $-8M | $-13M | $-16M | · | $-23M | $-19M | $-18M | $-21M | $-33M | |
| Stockholders' Equity | $-1.39B | $-1.45B | $-1.39B | $-1.50B | $-1.63B | $-1.92B | $-1.91B | $-1.82B | $-1.44B | $-1.43B | · | $-1.46B | $-1.49B | $-1.45B | · | $-1.79B | |
| Liabilities + Equity | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Shares Outstanding | 141,010,284 | 140,916,712 | 138,626,917 | 140,119,616 | 140,119,616 | 140,302,924 | 138,919,641 | 138,936,058 | 138,960,194 | 138,966,388 | · | 136,772,094 | 136,802,806 | 136,749,427 | · | 134,698,067 |
현금 흐름 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $108M | $114M | $108M | $108M | $105M | $105M | $129M | $117M | $125M | $115M | $121M | $128M | $124M | $132M | $136M | $137M | |
| Stock-based Comp | $2M | $3M | $5M | $-1M | $3M | $4M | $5M | $4M | $2M | $6M | $6M | $6M | $4M | $6M | $6M | $6M | |
| Operating Cash Flow | $88M | $-297M | $266M | $69M | $88M | $120M | $216M | $67M | $101M | $96M | $90M | $29M | $86M | $5M | $9M | $137M | |
| CapEx | $76M | $76M | $94M | $65M | $91M | $85M | $109M | $70M | $88M | $93M | $110M | $130M | $105M | $122M | $131M | $93M | |
| Investing Cash Flow | $-23M | $1.02B | $142M | $-81M | $342M | $444M | $-143M | $75M | $-108M | $-99M | $180M | $-101M | $-86M | $-19M | $-52M | $30M | |
| Net Debt Issued | · | $-351M | · | · | · | $-1.09B | · | · | · | $-885M | · | · | · | $-757M | · | · | |
| Financing Cash Flow | $-628M | $-274M | $-271M | $-321M | $-405M | $-170M | $-69M | $-148M | $-2M | $13M | $-323M | $45M | $-26M | $40M | $-139M | $-213M | |
| Net Change in Cash | $-563M | $452M | $137M | $-333M | $25M | $394M | $4M | $-6M | $-9M | $10M | $-53M | · | · | $26M | $-182M | $-46M | |
| Taxes Paid | $61M | $0 | $441M | $-91M | $181M | $80M | $303M | $-48M | $-84M | $0 | $152M | $-24M | $-37M | · | $0 | $0 | |
| Free Cash Flow | · | $-373M | · | · | · | $35M | · | · | · | $3M | · | · | · | $-117M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| Net Margin | 2.5% | -2.0% | · | 4.2% | 9.0% | -0.41% | · | -12.7% | -0.41% | -1.3% | · | -2.9% | -1.2% | -1.6% | · | -1.4% | |
| Pretax Margin | 6.4% | 2.2% | · | -0.06% | 14.0% | 2.1% | · | -13.6% | 1.6% | 0.70% | · | -1.1% | 1.3% | 0.19% | · | 2.3% | |
| EBITDA Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| ROA | 0.54% | -0.43% | · | 0.96% | 2.0% | -0.09% | · | -2.7% | -0.09% | -0.28% | · | -0.62% | -0.26% | -0.34% | · | -0.27% | |
| ROE | -4.6% | 3.4% | · | -7.8% | -18.4% | 0.78% | · | 23.8% | 0.89% | 2.9% | · | 5.6% | 2.4% | 3.6% | · | 2.5% | |
| ROIC | 2.8% | -1.3% | · | -228.6% | 4.1% | 1.1% | · | -1.8% | 1.2% | -0.62% | · | 2.6% | 0.12% | -6.8% | · | 0.00% |
유동성 및 지급능력 4
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | · | 1.5 | 1.6 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.2 | 1.2 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 | |
| LT Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.5 |
가치 평가 (TTM) 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12.01B | $12.34B | · | $12.47B | $12.52B | $12.53B | · | $12.46B | $12.48B | $12.45B | · | $12.33B | $12.18B | $12.18B | · | $12.19B | |
| Net Income TTM | $424M | $341M | · | $8M | $-135M | $-458M | · | $-536M | $-183M | $-221M | · | $-222M | $-457M | $-420M | · | $-258M | |
| Market Cap | $471M | $414M | · | $450M | $476M | $379M | · | $843M | $467M | $486M | · | $397M | $602M | $670M | · | $290M | |
| Enterprise Value | $9.87B | $9.83B | · | $10.92B | $10.86B | $11.25B | · | $12.28B | $11.93B | $11.97B | · | $12.13B | $12.21B | $12.22B | · | $11.93B | |
| P/E | 1.1 | 1.2 | · | · | -3.2 | -0.8 | · | -1.5 | -2.4 | -2.1 | · | -1.7 | -1.2 | -1.5 | · | -1.1 | |
| P/S | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| P/B | -0.3 | -0.3 | · | -0.3 | -0.3 | -0.2 | · | -0.5 | -0.3 | -0.3 | · | -0.3 | -0.4 | -0.5 | · | -0.2 | |
| P / Cash Flow | · | -1.4 | · | · | · | 3.2 | · | · | · | 5.1 | · | · | · | 134.0 | · | · | |
| P / FCF | · | -1.1 | · | · | · | 10.8 | · | · | · | 162.1 | · | · | · | -5.7 | · | · | |
| EV / EBITDA | 25.4 | 35.0 | · | 44.9 | 21.2 | 39.6 | · | -59.9 | 50.1 | 51.8 | · | 70.1 | 49.6 | 58.2 | · | 58.5 | |
| EV / FCF | · | -26.4 | · | · | · | 321.5 | · | · | · | 3990.5 | · | · | · | -104.5 | · | · | |
| EV / Revenue | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Earnings Yield | 93.7% | 85.7% | · | 0.00% | -31.2% | -128.5% | · | -66.9% | -41.7% | -48.6% | · | -58.6% | -80.2% | -66.3% | · | -93.0% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B |
| 영업이익률 % | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% |
| 순이익 | $509M | $-516M | $-133M | $46M | $230M |
| 희석 EPS | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 |
| 유동비율 | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 |
| 당좌 비율 | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $208M | $120M | $-257M | $-115M | $-600M |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 201개의 제출자 · $341.1M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 37 (+19 이전 분기 대비) | 24 (+4 이전 분기 대비) | 65 (+4 이전 분기 대비) | 49 (-12 이전 분기 대비) | +15.7M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| CastleKnight Management LP | $44,704,517 | 13,384,586 | 13.10% | 주식 |
| Apollo Management Holdings, L.P. | $39,610,817 | 11,859,526 | 11.61% | 주식 |
| Eversept Partners, LP | $26,267,680 | 7,864,575 | 7.70% | 주식 |
| VANGUARD GROUP INC | $25,789,362 | 8,265,821 | 7.56% | 주식 |
| NOMURA HOLDINGS INC | $22,388,384 | 6,703,109 | 6.56% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $17,668,370 | 5,289,931 | 5.18% | 주식 |
| WHITEBOX ADVISORS LLC | $12,467,362 | 3,732,743 | 3.65% | 주식 |
| STATE STREET CORP | $10,226,622 | 3,061,863 | 3.00% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10,082,117 | 3,018,598 | 2.96% | 주식 |
| Saba Capital Management, L.P. | $9,626,444 | 2,882,169 | 2.82% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $9,084,165 | 2,719,143 | 2.66% | 주식 |
| Owl Creek Asset Management, L.P. | $8,452,277 | 2,530,622 | 2.48% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8,176,380 | 2,448,018 | 2.40% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $7,510,531 | 2,248,662 | 2.20% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $7,365,822 | 2,205,336 | 2.16% | 주식 |
| Diameter Capital Partners LP | $6,138,793 | 1,837,962 | 1.80% | 주식 |
| TWO SIGMA ADVISERS, LP | $5,816,476 | 1,864,255 | 1.70% | 주식 |
| CARRONADE CAPITAL MANAGEMENT, LP | $5,230,000 | 1,565,847 | 1.53% | 주식 |
| Allianz Asset Management GmbH | $5,167,919 | 1,547,281 | 1.51% | 주식 |
| D. E. Shaw & Co., Inc. | $4,779,143 | 1,430,881 | 1.40% | 주식 |
| Silver Rock Financial LP | $3,674,000 | 1,100,000 | 1.08% | 주식 |
| CITADEL ADVISORS LLC | $3,177,085 | 951,223 | 0.93% | 주식 |
| Assenagon Asset Management S.A. | $2,788,275 | 834,813 | 0.82% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $2,642,231 | 791,087 | 0.77% | 주식 |
| BANK OF AMERICA CORP /DE/ | $2,566,736 | 768,484 | 0.75% | 주식 |
| Jefferies Financial Group Inc. | $2,481,286 | 742,900 | 0.73% | 주식 |
| Alta Fundamental Advisers LLC | $2,161,411 | 647,129 | 0.63% | 주식 |
| GOLDMAN SACHS GROUP INC | $2,016,194 | 603,651 | 0.59% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $1,701,580 | 509,455 | 0.50% | 주식 |
| ExodusPoint Capital Management, LP | $1,664,603 | 498,384 | 0.49% | 주식 |
| READYSTATE ASSET MANAGEMENT LP | $1,657,729 | 496,326 | 0.49% | 주식 |
| WOLVERINE ASSET MANAGEMENT LLC | $1,339,674 | 401,100 | 0.39% | 콜 옵션 |
| Helix Partners Management LP | $1,336,000 | 400,000 | 0.39% | 주식 |
| Bank of New York Mellon Corp | $1,325,679 | 396,910 | 0.39% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $1,280,940 | 383,515 | 0.38% | 주식 |
| Voleon Capital Management LP | $1,247,032 | 373,363 | 0.37% | 주식 |
| TUDOR INVESTMENT CORP ET AL | $999,388 | 299,218 | 0.29% | 주식 |
| Pathstone Holdings, LLC | $895,621 | 268,150 | 0.26% | 주식 |
| Prescott Group Capital Management, L.L.C. | $863,076 | 258,406 | 0.25% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $835,000 | 250,000 | 0.24% | 풋 옵션 |
| FEDERATED HERMES, INC. | $812,599 | 243,293 | 0.24% | 주식 |
| LPL Financial LLC | $737,239 | 220,730 | 0.22% | 주식 |
| IEQ CAPITAL, LLC | $657,963 | 196,995 | 0.19% | 주식 |
| RHUMBLINE ADVISERS | $543,412 | 162,701 | 0.16% | 주식 |
| Nuveen, LLC | $535,683 | 160,384 | 0.16% | 주식 |
| BOOTHBAY FUND MANAGEMENT, LLC | $506,701 | 151,707 | 0.15% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $501,668 | 150,200 | 0.15% | 콜 옵션 |
| Caption Management, LLC | $501,000 | 150,000 | 0.15% | 콜 옵션 |
| Nuveen Asset Management, LLC | $479,548 | 160,384 | 0.14% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $442,056 | 132,352 | 0.13% | 주식 |
| DEUTSCHE BANK AG\ | $423,131 | 126,686 | 0.12% | 주식 |
| State of Wyoming | $386,675 | 115,771 | 0.11% | 주식 |
| CAHABA WEALTH MANAGEMENT, INC. | $367,400 | 110,000 | 0.11% | 주식 |
| STRS OHIO | $334,000 | 100,000 | 0.10% | 주식 |
| EQUITABLE TRUST CO | $334,000 | 100,000 | 0.10% | 주식 |
| Turtle Creek Wealth Advisors, LLC | $334,000 | 100,000 | 0.10% | 주식 |
| Parkwoods Wealth Partners, LLC | $330,319 | 98,898 | 0.10% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $322,096 | 96,436 | 0.09% | 주식 |
| CITIGROUP INC | $321,361 | 96,216 | 0.09% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $311,640 | 106,000 | 0.09% | 주식 |
| Lombard Odier Asset Management (USA) Corp | $297,260 | 89,000 | 0.09% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $287,908 | 86,200 | 0.08% | 풋 옵션 |
| NorthCrest Asset Manangement, LLC | $283,320 | 76,573 | 0.08% | 주식 |
| MetLife Investment Management, LLC | $278,232 | 83,303 | 0.08% | 주식 |
| CITADEL ADVISORS LLC | $242,818 | 72,700 | 0.07% | 풋 옵션 |
| LAZARD ASSET MANAGEMENT LLC | $240,887 | 72,122 | 0.07% | 주식 |
| Cetera Investment Advisers | $223,339 | 66,868 | 0.07% | 주식 |
| Mariner, LLC | $222,538 | 66,627 | 0.07% | 주식 |
| Cerity Partners LLC | $211,102 | 63,204 | 0.06% | 주식 |
| Apollon Wealth Management, LLC | $203,453 | 60,914 | 0.06% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $199,755 | 59,807 | 0.06% | 주식 |
| JANE STREET GROUP, LLC | $179,692 | 53,800 | 0.05% | 콜 옵션 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $176,339 | 128,756 | 0.05% | 주식 |
| Invesco Ltd. | $171,559 | 51,365 | 0.05% | 주식 |
| CITADEL ADVISORS LLC | $153,640 | 46,000 | 0.05% | 콜 옵션 |
| MERCER GLOBAL ADVISORS INC /ADV | $150,911 | 45,183 | 0.04% | 주식 |
| Schonfeld Strategic Advisors LLC | $147,660 | 44,210 | 0.04% | 주식 |
| Vanguard Global Advisers, LLC | $144,134 | 43,154 | 0.04% | 주식 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $136,659 | 40,916 | 0.04% | 주식 |
| Red Door Wealth Management, LLC | $130,260 | 39,000 | 0.04% | 주식 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $128,810 | 38,566 | 0.04% | 주식 |
| BlackRock, Inc. | $126,606 | 37,906 | 0.04% | 주식 |
| XTX Topco Ltd | $126,098 | 37,754 | 0.04% | 주식 |
| GROUP ONE TRADING LLC | $123,633 | 37,016 | 0.04% | 주식 |
| Bison Wealth, LLC | $121,992 | 33,150 | 0.04% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $116,957 | 35,017 | 0.03% | 주식 |
| Nebula Research & Development LLC | $116,025 | 34,125 | 0.03% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $113,724 | 34,049 | 0.03% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $111,419 | 33,359 | 0.03% | 주식 |
| Quantbot Technologies LP | $110,450 | 33,069 | 0.03% | 주식 |
| WOLVERINE TRADING, LLC | $108,016 | 34,400 | 0.03% | 콜 옵션 |
| INTECH INVESTMENT MANAGEMENT LLC | $107,535 | 32,196 | 0.03% | 주식 |
| Advisory Services Network, LLC | $105,845 | 31,690 | 0.03% | 주식 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $105,537 | 31,598 | 0.03% | 주식 |
| Independent Advisor Alliance | $99,766 | 29,870 | 0.03% | 주식 |
| Callan Family Office, LLC | $96,195 | 28,801 | 0.03% | 주식 |
| CAPTRUST FINANCIAL ADVISORS | $91,736 | 27,466 | 0.03% | 주식 |
| Brevan Howard Capital Management LP | $91,125 | 27,283 | 0.03% | 주식 |
| Atom Investors LP | $90,527 | 27,104 | 0.03% | 주식 |
| Lakeview Capital Partners, LLC | $89,580 | 29,960 | 0.03% | 주식 |
회사 내부자 57 명의 내부자 · 29 임원 · 23 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Kevin J Hammons | CEO | 2026년 3월 1일 A | 895,545 | 0 | 0 | $0 |
| Tim Hingtgen | CEO | 2025년 3월 1일 A | 1,388,781 | 0 | 0 | $0 |
| Jason K Johnson | EVP & CFO | 2026년 3월 1일 A | 268,439 | 0 | 0 | $0 |
| Thomas J Aaron | EVP and CFO | 2019년 12월 7일 F | 241,515 | 0 | 0 | $0 |
| Larry W Cash | President and CFO | 2017년 3월 1일 A | 568,152 | 0 | 0 | $0 |
| Miguel S Benet | President and CMO | 2025년 3월 1일 D | 47,635 | 0 | 0 | $0 |
| Austen D Mason | Regional President | 2025년 3월 1일 A | 142,500 | 0 | 0 | $0 |
| Mark B Medley | Regional President | 2025년 3월 1일 A | 128,637 | 0 | 0 | $0 |
| Chad A Campbell | Regional President | 2025년 3월 1일 A | 136,815 | 0 | 0 | $0 |
| Charles J Cova | Regional President | 2024년 3월 1일 A | 58,701 | 0 | 0 | $0 |
| Lynn T Simon | President and CMO | 2024년 3월 1일 A | 482,657 | 0 | 0 | $0 |
| Beryl Ramsey | Division President | 2019년 3월 1일 A | 62,969 | 0 | 0 | $0 |
| Patton Paul Smith | Division President | 2019년 3월 1일 F | 119,017 | 0 | 0 | $0 |
| Iii John W Mcclellan | Division President | 2017년 3월 1일 A | 41,242 | 0 | 0 | $0 |
| Robert O Horrar | Division President | 2017년 3월 1일 A | 68,649 | 0 | 0 | $0 |
| Martin Bonick | Division President | 2017년 3월 1일 A | 100,458 | 0 | 0 | $0 |
| Michael T Portacci | Division President | 2017년 3월 1일 A | 110,156 | 0 | 0 | $0 |
| Thomas Daniel Miller | Division President | 2016년 3월 1일 A | 112,107 | 0 | 0 | $0 |
| David Lewis Miller | President and COO | 2016년 3월 1일 A | 440,840 | 0 | 0 | $0 |
| William S Hussey | Division President | 2015년 10월 28일 M | 121,568 | 0 | 0 | $0 |
| Martin Dewayne Smith | Division President | 2015년 6월 3일 M | 94,111 | 0 | 0 | $0 |
| Gary D Newsome | Division President - Group Ops | 2008년 8월 25일 M | 118,286 | 0 | 0 | $0 |
| David V. Rice | EVP-Clinical Operations & CMO | 2026년 6월 1일 A | 30,000 | 0 | 0 | $0 |
| Phillip A. Posey | SVP & CAO | 2026년 3월 1일 A | 51,736 | 0 | 0 | $0 |
| Justin D Pitt | Pres,Chief Legal&Admin Officer | 2026년 3월 1일 A | 287,750 | 0 | 0 | $0 |
| Kevin A Stockton | EVP, Operations & Development | 2026년 3월 1일 A | 208,290 | 0 | 0 | $0 |
| Rachel A Seifert | Executive VP and Secretary | 2017년 3월 1일 F | 243,065 | 0 | 0 | $0 |
| Mark T Buford | SVP/Chief Accounting Officer | 2012년 2월 25일 F | 78,379 | 0 | 0 | $0 |
| Martin G Schweinhart | Senior Vice President | 2006년 3월 1일 A | 40,354 | 0 | 0 | $0 |
| Ranga K Krishnan | 이사 | 2026년 6월 30일 M | 170,023 | 0 | 0 | $0 |
| Fawn D Lopez | 이사 | 2026년 3월 1일 A | — | 0 | 0 | $0 |
| Ronald L Burgess JR | 이사 | 2026년 3월 1일 A | — | 0 | 0 | $0 |
| Susan W Brooks | 이사 | 2026년 3월 1일 A | 108,695 | 0 | 0 | $0 |
| Hubert James Williams | 이사 | 2026년 3월 1일 A | 211,863 | 0 | 0 | $0 |
| Joseph Arthur Hastings | 이사 | 2026년 3월 1일 A | 0 | 0 | 0 | $0 |
| Elizabeth T Hirsch | 이사 | 2026년 3월 1일 A | 162,059 | 0 | 0 | $0 |
| James S. Ely III | 이사 | 2026년 3월 1일 A | 412,876 | 0 | 0 | $0 |
| William Norris Jennings | 이사 | 2026년 3월 1일 A | 78,468 | 0 | 0 | $0 |
| John A Fry | 이사 | 2026년 3월 1일 A | 268,966 | 0 | 0 | $0 |
| John A Clerico | 이사 | 2026년 3월 1일 A | 368,763 | 0 | 0 | $0 |
| Michael Dinkins | 이사 | 2026년 3월 1일 A | 225,882 | 0 | 0 | $0 |
| Wayne T Smith | 이사 | 2026년 3월 1일 A | 5,217,579 | 0 | 0 | $0 |
| Julia B North | 이사 | 2021년 3월 1일 A | 162,056 | 0 | 0 | $0 |
| Mitchell H Watson JR | 이사 | 2017년 5월 16일 M | 22,594 | 0 | 0 | $0 |
| Harvey Klein MD | 이사 | 2010년 3월 15일 M | 10,383 | 0 | 0 | $0 |
| Dale F Frey | 이사 | 2008년 3월 31일 A | 20,000 | 0 | 0 | $0 |
| Thomas H Lister | 이사 | 2004년 9월 21일 S | 0 | 0 | 0 | $0 |
| Thodore Forstmann | 이사 | 2004년 9월 21일 S | 0 | 0 | 0 | $0 |
| Sandra Horbach | 이사 | 2004년 9월 21일 S | 0 | 0 | 0 | $0 |
| Robert J Dole | 이사 | 2004년 5월 6일 S | 0 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 제출 서류 | 2021년 3월 11일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 36 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| BSJR · Invesco Exchange-Traded Self-Indexe… | 2.68% | 21,287,000 | 2026년 8월 8일 | 일간 |
| EBIT · Harbor ETF Trust | 0.48% | 19,323 NS | 2026년 4월 30일 | N-PORT |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0.35% | 1,058,000 PA | 2026년 8월 8일 | 일간 |
| DFVE · DoubleLine ETF Trust | 0.20% | 18,550 NS | 2026년 3월 31일 | N-PORT |
| IWC · iShares Trust | 0.09% | 441,586 SH | 2026년 8월 8일 | 일간 |
| IHF · iShares Trust | 0.06% | 232,511 SH | 2026년 8월 8일 | 일간 |
| GSSC · Goldman Sachs ETF Trust | 0.04% | 132,595 NS | 2026년 5월 31일 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 113,109 SH | 2026년 8월 8일 | 일간 |
| NEAR · iShares U.S. ETF Trust | 0.03% | 1,304,000 SH | 2026년 8월 8일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 253,747 SH | 2026년 8월 8일 | 일간 |
| IWN · iShares Trust | 0.02% | 1,218,442 SH | 2026년 8월 8일 | 일간 |
| IWM · iShares Trust | 0.01% | 3,418,265 SH | 2026년 8월 8일 | 일간 |
| FNDX · SCHWAB STRATEGIC TRUST | 0.01% | 1,126,552 NS | 2026년 5월 31일 | N-PORT |
| RSSL · Global X Funds | 0.01% | 56,434 NS | 2026년 4월 30일 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.01% | 53,684 NS | 2026년 5월 31일 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 746,733 SH | 2026년 8월 8일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.01% | 349,881 SH | 2026년 8월 8일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.01% | 466,961 NS | 2026년 4월 30일 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 6,034 NS | 2026년 5월 31일 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 546,576 NS | 2026년 5월 31일 | N-PORT |
| UWM · ProShares Trust | 0.01% | 4,719 NS | 2026년 5월 31일 | N-PORT |
| URTY · ProShares Trust | 0.00% | 4,772 NS | 2026년 5월 31일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 5,006 NS | 2026년 5월 31일 | N-PORT |
| HDG · ProShares Trust | 0.00% | 120 NS | 2026년 5월 31일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 202,789 NS | 2026년 4월 30일 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 33,838 NS | 2026년 4월 30일 | N-PORT |
| ITOT · iShares Trust | 0.00% | 203,866 SH | 2026년 8월 8일 | 일간 |
| IWV · iShares Trust | 0.00% | 41,727 SH | 2026년 8월 8일 | 일간 |
| DCOR · Dimensional ETF Trust | 0.00% | 6,184 NS | 2026년 4월 30일 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 31,135 NS | 2026년 4월 30일 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 70,316 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1,347,195 SH | 2026년 8월 8일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3,813,888 SH | 2026년 8월 8일 | 일간 |
| VPLS · VANGUARD MALVERN FUNDS | 0.00% | 20,000 PA | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9,817 SH | 2026년 8월 8일 | 일간 |
| DFSU · Dimensional ETF Trust | 0.00% | 24 NS | 2026년 4월 30일 | N-PORT |